CARILEX MEDICAL INC.

As of June 30, 2026, CARILEX MEDICAL INC. carries a market capitalization of 655.82M, placing it among publicly traded companies globally. Its enterprise value stands at 578.26M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of June 30, 2026, CARILEX MEDICAL INC. has 20.30M shares outstanding.

These figures are as of June 30, 2026.

As of June 30, 2026, CARILEX MEDICAL INC. maintains a current ratio of 1.97, meaning it holds 2.0x the short-term assets needed to cover near-term liabilities.

As of the close on October 22, 2026, CARILEX MEDICAL INC.'s stock has declined approximately 16.82% over the past 52 weeks. The 50-day moving average sits at 32.13, while the 200-day moving average is 34.79.

As of June 30, 2026, CARILEX MEDICAL INC. holds 206.13M in cash and equivalents against 128.57M in total debt, resulting in a net debt position of -106.13M. Total book value stands at 296.69M, with working capital of 214.56M providing operational flexibility.